Avita Medical Q3 net loss narrows 53% year over year to $6.22 million; Q3 revenue rises 53% year over year to $26.1 million

Bitget2026/11/05 21:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Avita Medical’s third-quarter 2026 net loss narrowed 53% year over year to $6.22 million.
Revenue climbed 53% year over year to $26.1 million, while gross margin rose to 84%.
A $10 million credit facility draw following quarter-end strengthened liquidity; improved operating performance and liquidity alleviated going-concern doubts.
Medicare finalized national physician payment values and simplified billing codes for RECELL procedures, effective January 1, 2027.
Full-year 2026 revenue guidance rose to $92 million–$94 million; fourth-quarter cash flow breakeven remains expected.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avita Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611051605PRIMZONEFULLFEED9871529) on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Avita Medical Q3 net loss narrows 53% year over year to $6.22 million; Q3 revenue rises 53% year over year to $26.1 million

You may also like

Crypto prices